Navigation Links
Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market
Date:8/20/2008

SEATTLE, Aug. 20 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX: ONY) announced today that it received a letter from The Nasdaq Stock Market on August 14, 2008 indicating that Oncothyreon does not comply with the requirements for continued listing on The NASDAQ Global Market because it does not meet the maintenance standard that specifies, among other things, that (i) the market value of Oncothyreon's common stock be at least $50 million as required by Marketplace Rule 4450(b)(1)(A) or (ii) total assets and total revenue be at least $50 million as set forth in Marketplace Rule 4450(b)(1)(B). This notification has no immediate effect on the listing of Oncothyreon's common stock on The NASDAQ Global Market.

Oncothyreon may regain compliance with the minimum market value of listed securities standard if, at anytime prior to September 15, 2008, the market value of Oncothyreon's common stock is at least $50 million in the aggregate, or approximately $2.57 per share, for a minimum of ten consecutive business days (or such longer period of time as may be required by Nasdaq, at its discretion), based upon 19,492,432 shares outstanding as of August 14, 2008.

If Oncothyreon fails to regain compliance with The NASDAQ Global Market listing standards by September 15, 2008, Oncothyreon may appeal Nasdaq's determination to the Nasdaq Listing Qualifications Panel. This appeal process may take several weeks, during which time its common stock would continue to trade on The NASDAQ Global Market.

In addition, Oncothyreon believes that it currently meets the standards for listing on The NASDAQ Capital Market, which requires, among others things, stockholders' equity of at least $2.5 million or minimum market value of listed securities of at least $35 million. If Oncothyreon continues to meet such standards, it may choose at any time prior to the end of the appeal process to apply to transfer the listing of its common stock to The NASDAQ Capita
'/>"/>

SOURCE Oncothyreon Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Oncothyreon initiates Phase 1 trial of PX-866 cancer compound
2. Oncothyreon initiates Phase 1b trial of PX-12 in patients with advanced metastatic cancer
3. Oncothyreon to receive milestone payment
4. Oncothyreon Reports First Quarter 2008 Financial Results
5. Oncothyreon files investigational new drug application for PX-866 oncology compound
6. Data for Oncothyreons PX-12 and PX-866 presented at AACR Annual Meeting
7. Oncothyreon announces data from multiple small molecule programs to be presented at American Association of Cancer Research Annual Meeting
8. Oncothyreon announces effectiveness of shelf registration statement
9. Oncothyreon announces issuance of patent for PX-867
10. Oncothyreon to present at upcoming investment conferences
11. Oncothyreon reports full year and fourth quarter 2007 financial results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... July 30, 2015   GenoSpace , a ... interpretation and analysis of genomic and other biomedical ... has joined the company as Vice President of ... http://photos.prnewswire.com/prnh/20150730/250931 "GenoSpace partners with ... interpret, analyze and explore complex sets of genomic, ...
(Date:7/30/2015)... ... ... The 2015 Market Research Report on the Global Propanol Industry ... market with a focus on the Chinese situation. Major companies included in the propanol ... Sanofi, Royal Dutch Shell, LG Chem and Zhejiang Xinhua Chemical. , The report provides ...
(Date:7/30/2015)... ... July 30, 2015 , ... Leading ... clinical study of its canine osteoarthritis stem cell product, currently under development for ... KS) and will be marketed in the US by Aratana. This product, termed ...
(Date:7/30/2015)... , Inc. (NASDAQ: SNMX ), a leading company ... commercialize novel flavor ingredients for the food, beverage, and ... second quarter 2015. "Moving into the ... achieve our commercial and financial goals," stated John Poyhonen, ... our last quarterly earnings report, our two partners have ...
Breaking Biology Technology:GenoSpace Introduces Matthew Fischer as Vice President of Sales and Marketing 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9
... BIOFUEL ENERGY CORP. (Nasdaq: BIOF ... 2010 results.  For the quarter ended September 30, 2010, revenues ... million, compared to revenues of $91.1 million and a net ...  Net loss attributable to common shareholders was $1.4 million, or ...
... can wear on your nerves, but it really does ... in automotive fuel cells. Before large fleets of fuel-cell-powered ... find a way to protect the platinum, the most ... amount needed to make catalytically active electrodes. Now, ...
... Corporation (Nasdaq: DNDN ) today announced ... post-approval supplement to the PROVENGE® (sipuleucel-T) Biologics License ... facility. Dendreon is requesting licensure for an additional ... Food and Drug Administration (FDA) review for a ...
Cached Biology Technology:BioFuel Energy Reports Third Quarter Results 2BioFuel Energy Reports Third Quarter Results 3BioFuel Energy Reports Third Quarter Results 4BioFuel Energy Reports Third Quarter Results 5New highly stable fuel-cell catalyst gets strength from its nano core 2New highly stable fuel-cell catalyst gets strength from its nano core 3Dendreon Submits Post-Approval Supplement to the PROVENGE Biologics License Application for New Jersey Manufacturing Facility 2
(Date:7/8/2015)... July 8, 2015  Trovagene, Inc. (NASDAQ: ... today announced the launch of a study that ... Cancer Monitoring℠ (PCM) technology for predicting response to ... a combination of the novel immunotherapy agents Yervoy® ... PD-1 inhibitor. The 50-patient study will be led ...
(Date:7/7/2015)... Research and Markets ... the "Capacitive Fingerprint Sensors Patent Landscape" ... date, fingerprint sensing technology is the most reliable ... well developed. This patent landscape focuses on fingerprint ... domain of capacitive fingerprint sensors is closely linked ...
(Date:7/7/2015)... Conn. , July 7, 2015 NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market announces a revised version ... this week. The commercial will air on CNBC in ... Los Angeles and San Francisco ... The commercial focuses on Wocket,s ability to replace all the cards ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
... deciphered the structure of an essential part of Mediator, a ... the transcription of DNA. The research adds an important ... deeper understanding of how cells translate genetic information into the ... July 3 advance online issue of the journal Nature ...
... have specially adapted self-cleaning feet which could have practical ... may provide a design for self-cleaning sticky surfaces, which ... especially in contaminating environments - medical bandages, tyre performance, ... at the University of Glasgow who will be presenting ...
... The question of why there are so many species in ... in marine biology. Below the waterline, about 30% of Hawai,i,s marine ... else on Earth one of the highest rates of endemism ... from? Hawai,i is famous for its adaptive radiations (the formation ...
Cached Biology News:Researchers decipher protein structure of key molecule in DNA transcription system 2Frog feet could solve a sticky problem 2Scientists discover that Hawai'i is not an evolutionary dead end for marine life 2
Miscellaneous: Versatile stain for staining RNA (bluish-purple), DNA (blue), proteins (red) and acid polysaccharides Assay: ~ 95 % Suitab tst: differential staining of nucleic acids and prote...
Screening test for the detection of Salmonella sp. by means of DNA amplification, subsequent molecular hybridization and detection on a microtitre plate....
... EPICENTREs patented MasterAmp™ 10X PCR ... performance and allows improved sensitivity and ... templates. Using MasterAmp™ PCR Enhancer in ... of DNA melting, increases enzyme?s thermal ...
... simple three step procedure (PCR, Exonuclease III ... in one day. The typical cloning efficiency ... , Features and Benefits: , , Universal ... any expression vector , High Cloning Efficiency ...
Biology Products: